rs144513453
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_001142800.2(EYS):c.8429C>T(p.Thr2810Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000862 in 1,551,440 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.8429C>T | p.Thr2810Ile | missense_variant | 43/43 | ENST00000503581.6 | |
PHF3 | NM_001370348.2 | c.*7894G>A | 3_prime_UTR_variant | 16/16 | ENST00000262043.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.8429C>T | p.Thr2810Ile | missense_variant | 43/43 | 5 | NM_001142800.2 | A2 | |
EYS | ENST00000370621.7 | c.8492C>T | p.Thr2831Ile | missense_variant | 44/44 | 1 | P2 | ||
PHF3 | ENST00000262043.8 | c.*7894G>A | 3_prime_UTR_variant | 16/16 | 5 | NM_001370348.2 | P1 | ||
PHF3 | ENST00000505138.1 | c.363+10240G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00411 AC: 625AN: 152068Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.000953 AC: 150AN: 157414Hom.: 0 AF XY: 0.000890 AC XY: 74AN XY: 83106
GnomAD4 exome AF: 0.000509 AC: 712AN: 1399254Hom.: 2 Cov.: 31 AF XY: 0.000480 AC XY: 331AN XY: 690120
GnomAD4 genome AF: 0.00411 AC: 625AN: 152186Hom.: 6 Cov.: 32 AF XY: 0.00433 AC XY: 322AN XY: 74400
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2020 | This variant is associated with the following publications: (PMID: 20537394, 20237254) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | EYS: BP4, BS1, BS2 - |
Retinitis pigmentosa 25 Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | Mar 06, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 17, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Jan 02, 2020 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 13, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 13, 2022 | Variant summary: EYS c.8429C>T (p.Thr2810Ile) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00095 in 157414 control chromosomes, predominantly at a frequency of 0.015 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 4.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in EYS causing Retinitis Pigmentosa phenotype (0.0034), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. Although reported in the literature among EYS variants unlikely to be pathogenic in a cohort of individuals with sporadic or autosomal recessive Retinitis Pigmentosa (example, Audo_2010), to our knowledge, no penetrant association of c.8429C>T in individuals affected with Retinitis Pigmentosa and no experimental evidence demonstrating its impact on protein function have been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and a predominant consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. - |
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at